MK0431 (Sitagliptin) Pioglitazone Add-on Study for Patients With Type 2 Diabetes Mellitus (0431-055)(COMPLETED)

NCT00372060 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

134

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: sitagliptin phosphate
DRUG: Comparator: sitagliptin phosphate (MK0431)
DRUG: Comparator: pioglitazone
DRUG: Comparator: placebo (unspecified)

Sponsor

Merck Sharp & Dohme LLC